NCT00041795 - Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2002

Conditions

Peripheral Nervous System DiseasesChemotherapy-Induced Peripheral Neuropathy

Interventions

DRUG

leteprinim potassium (Neotrofin)

Trial Locations (6)

NYU Medical Center, New York

The Sarah Cannon Cancer Center, Nashville

Washington University School of Medicine, St Louis

Providence Holy Cross Medical Center, Mission Hills

Providence St. Joseph Medical Center, Burbank

Alta Bates Comprehensive Cancer Center, Berkeley